190 related articles for article (PubMed ID: 11680650)
1. A revisit of mucosal IgA immunity and oral tolerance.
Fujihashi K; Kato H; van Ginkel FW; Koga T; Boyaka PN; Jackson RJ; Kato R; Hagiwara Y; Etani Y; Goma I; Fujihashi K; Kiyono H; McGhee JR
Acta Odontol Scand; 2001 Oct; 59(5):301-8. PubMed ID: 11680650
[TBL] [Abstract][Full Text] [Related]
2. A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants.
Fujihashi K; Koga T; van Ginkel FW; Hagiwara Y; McGhee JR
Vaccine; 2002 Jun; 20(19-20):2431-8. PubMed ID: 12057597
[TBL] [Abstract][Full Text] [Related]
3. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
[TBL] [Abstract][Full Text] [Related]
4. Impaired mucosal immune responses in interleukin 4-targeted mice.
Vajdy M; Kosco-Vilbois MH; Kopf M; Köhler G; Lycke N
J Exp Med; 1995 Jan; 181(1):41-53. PubMed ID: 7807021
[TBL] [Abstract][Full Text] [Related]
5. Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract.
Yamamoto M; Rennert P; McGhee JR; Kweon MN; Yamamoto S; Dohi T; Otake S; Bluethmann H; Fujihashi K; Kiyono H
J Immunol; 2000 May; 164(10):5184-91. PubMed ID: 10799877
[TBL] [Abstract][Full Text] [Related]
6. Strong mucosal adjuvanticity of cholera toxin within lipid particles of a new multiple emulsion delivery system for oral immunization.
Tomasi M; Dertzbaugh MT; Hearn T; Hunter RL; Elson CO
Eur J Immunol; 1997 Oct; 27(10):2720-5. PubMed ID: 9368632
[TBL] [Abstract][Full Text] [Related]
7. Adipose-Derived Mesenchymal Stem Cells Restore Impaired Mucosal Immune Responses in Aged Mice.
Aso K; Tsuruhara A; Takagaki K; Oki K; Ota M; Nose Y; Tanemura H; Urushihata N; Sasanuma J; Sano M; Hirano A; Aso R; McGhee JR; Fujihashi K
PLoS One; 2016; 11(2):e0148185. PubMed ID: 26840058
[TBL] [Abstract][Full Text] [Related]
8. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection.
Bromander AK; Ekman L; Kopf M; Nedrud JG; Lycke NY
J Immunol; 1996 Jun; 156(11):4290-7. PubMed ID: 8666800
[TBL] [Abstract][Full Text] [Related]
9. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.
Boyaka PN; Tafaro A; Fischer R; Leppla SH; Fujihashi K; McGhee JR
J Immunol; 2003 Jun; 170(11):5636-43. PubMed ID: 12759444
[TBL] [Abstract][Full Text] [Related]
10. Cholera toxin breakdowns oral tolerance via activation of canonical NF-κB.
Kim KJ; Kim HA; Seo KH; Lee HK; Kang BY; Im SY
Cell Immunol; 2013; 285(1-2):92-9. PubMed ID: 24140867
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of gut immunologic reactions: selective induction of distinct responses to Vibrio cholerae WO7 and its toxin.
Walia K; Vohra H; Singh H; Ganguly NK
Microbiol Immunol; 2000; 44(11):931-40. PubMed ID: 11145274
[TBL] [Abstract][Full Text] [Related]
12. CD19-deficient mice exhibit poor responsiveness to oral immunization despite evidence of unaltered total IgA levels, germinal centers and IgA-isotype switching in Peyer's patches.
Gärdby E; Lycke NY
Eur J Immunol; 2000 Jul; 30(7):1861-71. PubMed ID: 10940875
[TBL] [Abstract][Full Text] [Related]
13. A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses.
Shima H; Watanabe T; Fukuda S; Fukuoka S; Ohara O; Ohno H
Int Immunol; 2014 Nov; 26(11):619-25. PubMed ID: 24908678
[TBL] [Abstract][Full Text] [Related]
14. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
15. Oral vaccine models: multiple delivery systems employing tetanus toxoid.
Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR
Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173
[TBL] [Abstract][Full Text] [Related]
16. Modulating dendritic cells to optimize mucosal immunization protocols.
Williamson E; Westrich GM; Viney JL
J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
[TBL] [Abstract][Full Text] [Related]
17. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.
Mestecky J; Michalek SM; Moldoveanu Z; Russell MW
Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757
[TBL] [Abstract][Full Text] [Related]
18. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches.
Heritage PL; Underdown BJ; Arsenault AL; Snider DP; McDermott MR
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1256-62. PubMed ID: 9351630
[TBL] [Abstract][Full Text] [Related]
19. Strong differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvant.
Gärdby E; Wrammert J; Schön K; Ekman L; Leanderson T; Lycke N
J Immunol; 2003 Jan; 170(1):55-63. PubMed ID: 12496383
[TBL] [Abstract][Full Text] [Related]
20. The common mucosal immune system: from basic principles to enteric vaccines with relevance for the female reproductive tract.
McGhee JR; Xu-Amano J; Miller CJ; Jackson RJ; Fujihashi K; Staats HF; Kiyono H
Reprod Fertil Dev; 1994; 6(3):369-79. PubMed ID: 7831485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
